...
首页> 外文期刊>Cell death & disease. >SPATS2, negatively regulated by miR-145-5p, promotes hepatocellular carcinoma progression through regulating cell cycle
【24h】

SPATS2, negatively regulated by miR-145-5p, promotes hepatocellular carcinoma progression through regulating cell cycle

机译:通过MiR-145-5P负调节的SPATS2通过调节细胞周期来促进肝细胞癌进展

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Spermatogenesis associated serine rich 2 (SPATS2) has been reported to contribute to the tumorigenesis of multiple malignancies. The molecular function of SPATS2 in hepatocellular carcinoma (HCC) is still not fully understood. In this study, we aimed to investigate the expression pattern and function roles of SPATS2 in HCC. The regulation of SPATS2 expression was also explored. We found that SPATS2 was highly expressed in HCC tissues in comparison with that in adjacent normal tissues. High expression of SPATS2 was associated with vascular invasion, advanced TNM stages, tumor multiplicity, and poor survival. Functionally, SPATS2 was found to promote the proliferation and metastasis of HCC cells both in vitro and in vivo, while knockdown of SPATS2 enhanced apoptosis and G1 arrest of HCC cells in vitro. Mechanistically, bioinformatics analysis revealed that MiR-145-5p directly targeted SPATS2 and functional rescue experiments verified that MiR-145-5p overexpression could abolish the effect of SPATS2 on the regulation of HCC malignant phenotype. Taken together, our findings suggest that SPATS2 functions as an oncogene in HCC. The MiR-145-5p/SPATS2 axis provides a novel mechanism underlying HCC progression and may serve as a potential therapeutic target for HCC.
机译:据报道,精子发生相关的丝氨酸富含2(SPATS2),以有助于多种恶性肿瘤的肿瘤鉴定。渗透细胞癌(HCC)中斯PATS2的分子功能仍未完全理解。在这项研究中,我们旨在研究SPATS2在HCC中的表达模式和功能作用。还探讨了SPATS2表达的调节。我们发现,与在相邻的正常组织中,斯PATS2在HCC组织中高度表达。 SPATS2的高表达与血管侵袭,晚期TNM阶段,肿瘤多重和存活率不良有关。在功能上,发现斯PATS2促进体外和体内HCC细胞的增殖和转移,同时斯PATS2的敲低增强了体外凋亡和HCC细胞的凋亡和G1停滞。机械上,生物信息学分析显示,MIR-145-5P直接靶向斯PATS2和功能救援实验证实MIR-145-5P过表达可以消除SPATS2对HCC恶性表型调节的影响。我们的研究结果结合在一起,表明SPATS2用作HCC中的癌基因。 miR-145-5p / spats2轴提供了一种新的HCC进展的新机制,可以作为HCC的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号